Midazolam vs Pembrolizumab

## Midazolam vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Midazolam** and **Pembrolizumab**.

## Mechanism of Action

**Midazolam**: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Midazolam — 1.5-2.5 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Midazolam — C18H13ClFN3; Pembrolizumab — N/A.

**Molecular Weight**: Midazolam — 325.7670 g/mol; Pembrolizumab — N/A.

**Type**: Midazolam — Small molecule; Pembrolizumab — Antibody.